http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014171911-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_be41078385205036f284d26d8a1a2c87
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-22084
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-22067
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-320725
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-0105
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-0021
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-320758
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M25-01
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B17-3207
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-958
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B17-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M25-00
filingDate 2013-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_185b88efc018cc70b211f3e22d103d81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa1a0b8be386899f94d771b16d8d91ae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_531a24534c8e9812bc3286ceae177c54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40459c21f5210e999fa1ec972c523d34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_727625dc732b03b8bedf909129bce682
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e0b840200ac6b1486800e877ca4efba
publicationDate 2014-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2014171911-A1
titleOfInvention Apparatus and methods for clot dissolution
abstract Clot disruption and dissolution are achieved using a catheter having the ability to infuse a thrombolytic agent, aspirate clot and fluid, and allow passage of a guidewire. Optionally, the catheter may also include a mechanical agitator for further disrupt clot in the presence of the thrombolytic agent. A flow resistor in the catheter provides for infusion and/or aspiration to be concentrated primarily at a clot treatment area in a blood vessel while also providing optional infusion and/or aspiration distal to the treatment area. In some embodiments, infusion, aspiration and guidewire passage occur through a common lumen. The thrombolytic agent, such as tPA, streptokinase, or urokinase, is directly released into the clot at the point where the agitator is engaging the clot. In this way, the thrombolytic activity of the agent is enhanced and the dissolution of the clot is improved.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021003133-A1
priorityDate 2000-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7763010-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8535290-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6929633-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6663613-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8241241-B2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60946
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73073
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411130
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57323696
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8980
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID443939
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID440542
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406750
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87057681
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID442070
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6167
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396386
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402238
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396385
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406075
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405470
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400268
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396387
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID448812
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394110
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395471
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57199466
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226427710
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4763
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395470
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152951
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399659
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426377
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10351092
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395812
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60947
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226407194

Total number of triples: 68.